Waters Corporation: Leveraging High Quality Mass Spectrometry for Niche Markets

December 29, 2023

🌥️Trending News

Waters Corporation ($NYSE:WAT) is a specialist provider of excellence in mass spectrometry. The company specializes in providing high quality mass spectrometry instruments and services to the scientific community and niche markets. As a market leader, Waters Corporation has earned its reputation for providing technology that is consistently reliable and of the highest quality. Within the scientific community, Waters Corporation is known for developing and manufacturing mass spectrometry instruments, sample preparation and chromatography products, and consumables for laboratory analyses. Their products are used for a wide range of applications, including environmental monitoring, food safety analysis, medical research, biotechnology, drug discovery, and forensic science.

Additionally, their instruments are adopted in a variety of industries including pharmaceutical, clinical research, industrial chemicals, and petrochemical products. Waters Corporation also offers specialty services such as training workshops and seminars to help their customers gain the most out of their instruments. This allows them to stay up to date with the latest trends in mass spectrometry and sharpen their skills. Furthermore, their customer service team is available to provide technical assistance and offer solutions to any problems that may arise. With their comprehensive portfolio of products and services, Waters Corporation has become a trusted partner for many industries across the world. Overall, Waters Corporation is an industry leader when it comes to leveraging high quality mass spectrometry for niche markets. With a wide range of reliable products and services as well as customer support, they are able to meet the needs of different industries and remain a trusted partner in mass spectrometry.

Stock Price

On Thursday, WATERS CORPORATION opened at $334.1 and closed at $332.8, reflecting a marginal decrease of 0.1% from the last trading session. The company has a strong focus on providing innovative technologies to its customers, leveraging its mass spectrometry platform to achieve this end. WATERS CORPORATION’s products have become increasingly popular in niche markets such as the research and medical diagnostics industries.

Its products have been instrumental in helping organizations quickly analyze complex data sets in order to make informed decisions. The company is well positioned to capitalize on the growing demand for advanced mass spectrometry technologies going forward. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Waters Corporation. More…

    Total Revenues Net Income Net Margin
    3k 653.09 21.8%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Waters Corporation. More…

    Operations Investing Financing
    571.4 -1.47k 773.99
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Waters Corporation. More…

    Total Assets Total Liabilities Book Value Per Share
    4.5k 3.59k 15.32
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Waters Corporation are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    9.3% 10.7% 28.6%
    FCF Margin ROE ROA
    13.0% 63.8% 11.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale has recently conducted an analysis of WATERS CORPORATION‘s financials. According to our Star Chart, WATERS CORPORATION has a very high health score of 9/10 with regards to its cashflows and debt, signifying that it is capable of paying off debt and funding future operations. Additionally, our Star Chart also suggests that WATERS CORPORATION is strong in profitability, medium in growth and weak in asset and dividend. From this analysis, we classified WATERS CORPORATION as a ‘rhino’, a type of company we conclude that has achieved moderate revenue or earnings growth. This type of company could be attractive to various types of investors. For example, value investors may be drawn to the strong profitability and its low cost of capital. Growth investors may be interested in the medium growth rate and the potential for upside. Lastly, dividend investors may be drawn to the potential for dividend payment in the future. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    Waters Corporation is an American analytical instrument manufacturing company that specializes in liquid chromatography, mass spectrometry, and thermal analysis instruments. It has annual sales of over $2 billion and employs more than 6,000 people worldwide. Its products are used in the life sciences, pharmaceutical, and chemical industries. Waters Corporation’s main competitors are IQVIA Holdings Inc, Agilent Technologies Inc, Vijaya Diagnostic Centre Ltd.

    – IQVIA Holdings Inc ($NYSE:IQV)

    The company’s market cap as of 2022 was 39.27B and its ROE was 21.52%. The company is a global provider of information, innovative technology solutions, and real-world insights that help customers improve their well-being. The company offers a broad range of products and services that enable customers to manage their health and wellbeing.

    – Agilent Technologies Inc ($NYSE:A)

    Agilent Technologies, Inc. is a provider of life sciences, diagnostics, and applied chemical markets solutions. It operates through three segments: Life Sciences and Applied Markets Group, Diagnostics and Genomics Group, and Agilent CrossLab Group. The Life Sciences and Applied Markets Group segment offers application solutions that include chromatography, mass spectrometry, chemical analysis, and cellular analysis. The Diagnostics and Genomics Group segment provides in vitro diagnostic products and services. The Agilent CrossLab Group segment offers a range of services and consumables. Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, California.

    – Vijaya Diagnostic Centre Ltd ($BSE:543350)

    Vijaya Diagnostic Centre Ltd is a leading diagnostic centre in India with a market cap of 46.61B as of 2022. The company has a return on equity of 17.7%. The company offers a wide range of diagnostic services including X-rays, ultrasounds, MRI, and CT scans. The company also has a wide network of centres across India.

    Summary

    Waters Corporation is a leading provider of specialty analytical instruments, services, and software for laboratory and process-related applications. It is a niche company that specializes in mass spectrometry, an analytical technique used to identify and characterize substances. Analysts are optimistic on the company’s prospects, and have given it a “buy” rating on average. With its strong product portfolio and a large base of customers, Waters Corporation is well positioned to capitalize on its market potential in the near future.

    Recent Posts

    Leave a Comment